Human Reproduction, Vol. 14, No. 5, 1335-1337,
May 1999
© 1999 European Society of Human Reproduction and Embryology
Effects of 3 month therapy with danazol after laparoscopic surgery for stage III/IV endometriosis: a randomized study
Second Department of Obstetrics and Gynecology, University of Milano, Via Commenda 12, 20122 Milano, Italy
The effect of treatment with danazol was evaluated with respect to expectant management after laparoscopic conservative surgery. All patients conservatively operated at laparoscopy for stage IIIIV endometriosis from July 1994 to October 1996 were requested to enter the study. Patients who underwent surgery for recurrent endometriosis were excluded from the study, as well as patients who had taken hormonal therapies before laparoscopy. Informed consent was obtained from 77 women who were randomized after surgery to treatment with danazol 600 mg daily for 3 months (n = 36) or to expectant management (n = 41). All patients were regularly followed up every 6 months for evaluation of fertility, recurrence of pain symptoms and disease. During the follow-up, six (55%) of the 11 infertile women allocated to danazol and eight (50%) of the 16 given no treatment became pregnant (not significant). Moderate/severe pelvic pain recurred during follow-up in seven (23%) of the 31 women with pelvic pain allocated to the danazol group and nine (31%) of the 29 allocated to no treatment; the respective cumulative pain recurrence rates at 12 months were 26 and 34% (log rank test, not significant). Three women (8.3%) treated with danazol and six (15%) who received no treatment had disease recurrence as demonstrated by gynaecological examination and/or pelvic ultrasonography (not significant). Our results do not demonstrate a significant advantage of 3 month danazol therapy after laparoscopic surgery for stage IIIIV endometriosis with respect to postoperative expectant management.
Key words: danazol/endometriosis/laparoscopy
1 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S.-W. Guo Recurrence of endometriosis and its control Hum. Reprod. Update, July 1, 2009; 15(4): 441 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Koga, Y. Takemura, Y. Osuga, O. Yoshino, Y. Hirota, T. Hirata, C. Morimoto, M. Harada, T. Yano, and Y. Taketani Recurrence of ovarian endometrioma after laparoscopic excision Hum. Reprod., August 1, 2006; 21(8): 2171 - 2174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kennedy, A. Bergqvist, C. Chapron, T. D'Hooghe, G. Dunselman, R. Greb, L. Hummelshoj, A. Prentice, E. Saridogan, and on behalf of the ESHRE Special Interest Group for ESHRE guideline for the diagnosis and treatment of endometriosis Hum. Reprod., October 1, 2005; 20(10): 2698 - 2704. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Busacca, E. Somigliana, S. Bianchi, S. De Marinis, C. Calia, M. Candiani, and M. Vignali Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III-IV: a randomized controlled trial Hum. Reprod., November 1, 2001; 16(11): 2399 - 2402. [Abstract] [Full Text] [PDF] |
||||

